{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:17:42Z","timestamp":1789449462831,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jamda.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T05:21:15Z","timestamp":1286601675000},"page":"648-654","source":"Crossref","is-referenced-by-count":14,"title":["Patterns of Dementia Treatment Use in Assisted Living Facilities: A Cross-Sectional Study of 1975 Demented Residents"],"prefix":"10.1016","volume":"12","author":[{"given":"Nad\u00e8ge","family":"Barro-Belaygues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor Abellan","family":"van Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fati","family":"Nourhashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Soto-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gillette-Guyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2010.06.003_bib1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.1997.03550160083043","article-title":"Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer\u2019s Association, and the American Geriatrics Society","volume":"278","author":"Small","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2010.06.003_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3111\/13696990903004039","article-title":"Predicting time to nursing home placement based on activities of daily living scores\u2014a modelling analysis using data on Alzheimer\u2019s disease patients receiving rivastigmine or donepezil","volume":"12","author":"Hatoum","year":"2009","journal-title":"J Med Econ"},{"key":"10.1016\/j.jamda.2010.06.003_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/geront\/47.3.350","article-title":"Estimated prevalence of people with cognitive impairment: Results from nationally representative community and institutional surveys","volume":"47","author":"Bernstein","year":"2007","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2010.06.003_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(02)09461-8","article-title":"Medical Research Council Cognitive Function and Ageing Study. Prevalence of dementia in institutional care","volume":"360","author":"Matthews","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2010.06.003_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/geront\/40.6.663","article-title":"The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel","volume":"40","author":"Magaziner","year":"2000","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2010.06.003_bib6","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1532-5415.2007.01387.x","article-title":"Treatment of dementia in community-dwelling and institutionalized Medicare beneficiaries","volume":"55","author":"Gruber-Baldini","year":"2007","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2010.06.003_bib7","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1532-5415.2005.53551.x","article-title":"Mortality and adverse health events in newly admitted nursing home residents with and without dementia","volume":"53","author":"Magaziner","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2010.06.003_bib8","first-page":"405","article-title":"Prevalence of dementia and Alzheimer\u2019s disease among subjects aged 75 years or over: Updated results of the PAQUID cohort","volume":"159","author":"Ramaroson","year":"2003","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jamda.2010.06.003_bib9","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1001\/jama.2008.768","article-title":"Reporting dementia on the death certificates of nursing home residents dying with end-stage dementia","volume":"300","author":"Wachterman","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2010.06.003_bib10","article-title":"Diagnostic et prise en charge de la maladie d\u2019Alzheimer et des maladies apparent\u00e9es: Interventions m\u00e9dicamenteuses et non m\u00e9dicamenteuses","year":"2009","journal-title":"HAS"},{"key":"10.1016\/j.jamda.2010.06.003_bib11","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1532-5415.2001.49266.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer\u2019s disease in the nursing home setting","volume":"49","author":"Tariot","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2010.06.003_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jalz.2007.10.011","article-title":"Behavioral effects of current Alzheimer\u2019s disease treatments: A descriptive review","volume":"4","author":"Cummings","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2010.06.003_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1533317509332094","article-title":"Donepezil in severe Alzheimer\u2019s disease","volume":"24","author":"Winblad","year":"2009","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jamda.2010.06.003_bib14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(06)68350-5","article-title":"Donepezil in patients with severe Alzheimer\u2019s disease: Double-blind, parallel-group, placebo-controlled study","volume":"367","author":"Winblad","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2010.06.003_bib15","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000167267","article-title":"Donepezil treatment of severe Alzheimer\u2019s disease in nursing home settings. A responder analysis","volume":"26","author":"Jelic","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2010.06.003_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1543-5946(05)80020-0","article-title":"Effects of Rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer\u2019s disease: A 26-week, multicenter, open-label study","volume":"3","author":"Cummings","year":"2005","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2010.06.003_bib17","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1185\/030079904125004204","article-title":"Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer\u2019s disease: Results of a 52-week open-label study","volume":"20","author":"Aupperle","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jamda.2010.06.003_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0","article-title":"Memantine in severe dementia: Results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)","volume":"14","author":"Winblad","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2010.06.003_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000091790","article-title":"3-year study of donepezil therapy in Alzheimer\u2019s disease: Effects of early and continuous therapy","volume":"21","author":"Winblad","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2010.06.003_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jamda.2006.08.008","article-title":"The application of evidence-based principles of care in older persons (issue 5): Alzheimer\u2019s disease","volume":"8","author":"Zarowitz","year":"2007","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2010.06.003_bib21","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.revmed.2006.04.012","article-title":"Cholinesterase inhibitor therapy in long-term care settings","volume":"27","author":"Vantelon","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jamda.2010.06.003_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2146\/ajhp070622","article-title":"Treatment of Alzheimer\u2019s disease in the long-term-care setting","volume":"66","author":"Smith","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jamda.2010.06.003_bib23","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/j.1532-5415.2009.02552.x","article-title":"Cholinesterase inhibitor use in US nursing homes: Results from the national nursing home survey","volume":"57","author":"Seitz","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2010.06.003_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF03324534","article-title":"Donepezil use in US nursing homes","volume":"16","author":"Pedone","year":"2004","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jamda.2010.06.003_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12603-009-0197-4","article-title":"Descriptive study of nursing home residents from the REHPA network","volume":"13","author":"Rolland","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jamda.2010.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jamda.2010.06.003_bib27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL. A standardized measure of biological and psychological function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2010.06.003_bib28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1532-5415.2007.01377.x","article-title":"A population-based study of cholinesterase inhibitor use for dementia","volume":"55","author":"Herrmann","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2010.06.003_bib29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajgp.13.10.892","article-title":"Mental health-related drug utilization among older adults: Prevalence, trends, and costs","volume":"13","author":"Mamdani","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2010.06.003_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1041610209990354","article-title":"Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer\u2019s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine","volume":"21","author":"Rodda","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2010.06.003_bib31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs. atypical antipsychotic medications","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jamda.2010.06.003_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000278348","article-title":"Lower barthel index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease","volume":"29","author":"Formiga","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2010.06.003_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjopharm.2006.06.002","article-title":"Patterns of cholinesterase-inhibitor use in the nursing home setting: A retrospective analysis","volume":"4","author":"Dybicz","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1016\/j.jamda.2010.06.003_bib34","unstructured":"Food and Drug Administration. FDA approves expanded use of treatment for patients with severe Alzheimer\u2019s disease. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2006\/ucm108768.htm. Accessed January 10, 2010."},{"key":"10.1016\/j.jamda.2010.06.003_bib35","first-page":"1365","article-title":"Pharmacologic treatment of Alzheimer\u2019s disease: An update","volume":"68","author":"Delagarza","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jamda.2010.06.003_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jamda.2007.02.007","article-title":"The use of a cholinesterase inhibitor review committee in long-term care","volume":"8","author":"Lee","year":"2007","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"10.1016\/j.jamda.2010.06.003_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jamda.2010.06.003_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003672","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies","author":"Wild","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jamda.2010.06.003_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004747.pub2","article-title":"Cholinesterase inhibitors for Parkinson\u2019s disease dementia","author":"Maidment","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2010.06.003_bib40","unstructured":"Food and Drug Administration. FDA approves the first treatment for dementia of Parkinson\u2019s disease. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2006\/ucm108680.htm. Accessed January 10, 2010."},{"key":"10.1016\/j.jamda.2010.06.003_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1041610201007736","article-title":"Alzheimer\u2019s disease and other dementia in nursing homes: Levels of management and cost","volume":"13","author":"O\u2019Brien","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2010.06.003_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/gerona\/54.1.M25","article-title":"Characteristics of the SAGE database: A new resource for research on outcomes in long-term care. SAGE (Systematic Assessment of Geriatric drug use via Epidemiology) Study Group","volume":"54","author":"Bernabei","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861010002069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861010002069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T09:23:16Z","timestamp":1544174596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861010002069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1525861010002069"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2010.06.003","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}